Tumor Profiling in Head and Neck Cancer

With our advanced Technologies for Tumor Profiling, Creative Biolabs has developed a first-class platform for head and neck tumor profiling.

Introduction of Tumor Profiling in Head and Neck Cancer

Head and neck cancers are solid aggressive malignancy tumors, with considerable morbidity and mortality worldwide. It has high intra-tumoral heterogeneity, genetically and functionally, which contributes to the recurrence and metastasis after first-line chemotherapy treatment. The complex tumor microenvironment (TME) of head and neck cancers accelerates the pathogenesis and drug resistance development. Therefore, professional personalized medicine (shown in Fig.1) based on comprehensive tumor profiling could improve the therapeutic effectiveness of head and neck cancers.

Fig.1 Strategies to deal with TME immunosuppression. (Wang; et al, 2019)

Tumor Profiling in Head and Neck Cancer at Creative Biolabs

• Technologies for head and neck tumor profiling

With the advanced technologies for tumor profiling, Creative Biolabs could help provide insight into the heterogeneity among head and neck tumor cells.

• List of some head and neck tumor profiling biomarkers

• Applications of head and neck tumor profiling

• Workflow for head and neck tumor profiling

On-machine Detection

Data Interpretation

Sample Pretreatment

Data Acquisition

Report Delivery

Features of Tumor Profiling in Head and Neck Cancer at Creative Biolabs

• Advanced technical platform with high sensitivity, accuracy, and repeatability
• Rational programs with practiced expert teams

Creative Biolabs provides a first-class platform for head and neck tumor profiling. With industry-leading expertise and state-of-the-art single-use equipment, our service team has pioneered the head and neck tumor profiling area. Please contact us directly if you are interested in our services.

Reference

1. Wang, H.C.; et al. Targeting the immune microenvironment in the treatment of head and neck squamous cell carcinoma. Frontiers in Oncology. 2019, 9: 1084.

For Research Use Only | Not For Clinical Use